A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. and certain officers for alleged violations of federal securities laws. The lawsuit claims Park Ha engaged in a fraudulent stock promotion and market manipulation scheme involving social media misinformation and impersonation of financial professionals. It also alleges that the company failed to disclose material information about these activities and structured its IPO to facilitate manipulation. Investors who purchased Park Ha securities between December 27, 2024, and July 8, 2025, are encouraged to join the lawsuit, with a deadline to request lead plaintiff status by September 21, 2026.
VINCI published its half-year financial report for 2026, highlighting a 2% increase in revenue, including 4% growth in the second quarter. The company also reported a 4% rise in EBITDA and significant growth in earnings per share, reflecting strong o...
VINCI released its half-year financial report for 2026, showing a 2% increase in revenue, including a 4% growth in the second quarter. EBITDA also rose by 4%, reflecting solid operational performance. The company highlights its commitment to sustaina...
Orange published its interim financial report for the first half of 2026, showing a 3.5% increase in revenue and a 5.0% rise in EBITDAaL. The company continues to lead in telecommunications across Europe, Africa, and the Middle East, connecting 340 m...
A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. and some of its officers for allegedly misleading investors and violating federal securities laws. The complaint claims Park Ha was involved in a fraudulent stock p...
Uber has agreed to invest up to $1.2 billion in electric vehicle maker Rivian and plans to purchase up to 50,000 of Rivian's R2 electric vehicles. This deal highlights Uber's push into electric and autonomous vehicle technology, positioning Rivian as...
